Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
BJU International
|
November 3, 2010
Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity
Xavier Gamé, Shahid Khan, Jalesh N Panicker, et al.
Current Urology Reports
|
October 4, 2011
Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management
Arun Sahai, Eduardo Cortes, Jai Seth, et al.
The Journal of Urology
|
October 30, 2010
Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration
Soumendra N Datta, Alexander Roosen, Antony Pullen, et al.
Nature Clinical Practice. Urology
|
May 8, 2008
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract
Michael B Chancellor, Clare J Fowler, Apostolos Apostolidis, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
January 22, 2013
Inhibitory control task is decreased in vascular incontinence patients
Hiroyuki Haruta, Ryuji Sakakibara, Tsuyoshi Ogata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 15, 2013
Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly
Ryuji Sakakibara, Jalesh Panicker, Clare J Fowler, et al.
European Urology
|
August 18, 2009
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature
Alexander Roosen, Christopher R Chapple, Roger R Dmochowski, et al.
European Urology
|
July 13, 2004
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin
Ciaran M Brady, Apostolos Apostolidis, Yiangos Yiangou, et al.
BJU International
|
March 1, 2013
Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Jai H Seth, Arun Sahai, Mohammad S Khan, et al.
BJU International
|
November 1, 2007
Sacral neurostimulation for urinary retention: 10-year experience from one UK centre
Soumendra N Datta, Charlotte Chaliha, Anubha Singh, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
BJU International
|
November 3, 2010
Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity
Xavier Gamé, Shahid Khan, Jalesh N Panicker, et al.
Current Urology Reports
|
October 4, 2011
Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management
Arun Sahai, Eduardo Cortes, Jai Seth, et al.
The Journal of Urology
|
October 30, 2010
Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration
Soumendra N Datta, Alexander Roosen, Antony Pullen, et al.
Nature Clinical Practice. Urology
|
May 8, 2008
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract
Michael B Chancellor, Clare J Fowler, Apostolos Apostolidis, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
January 22, 2013
Inhibitory control task is decreased in vascular incontinence patients
Hiroyuki Haruta, Ryuji Sakakibara, Tsuyoshi Ogata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 15, 2013
Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly
Ryuji Sakakibara, Jalesh Panicker, Clare J Fowler, et al.
European Urology
|
August 18, 2009
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature
Alexander Roosen, Christopher R Chapple, Roger R Dmochowski, et al.
European Urology
|
July 13, 2004
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin
Ciaran M Brady, Apostolos Apostolidis, Yiangos Yiangou, et al.
BJU International
|
March 1, 2013
Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
Jai H Seth, Arun Sahai, Mohammad S Khan, et al.
BJU International
|
November 1, 2007
Sacral neurostimulation for urinary retention: 10-year experience from one UK centre
Soumendra N Datta, Charlotte Chaliha, Anubha Singh, et al.
Page
of 10